Skip to main content
. 2012 Sep 6;5:39. doi: 10.1186/1755-8794-5-39

Figure 3.

Figure 3

Characterization of CAFs from breast cancer subtypes by morphology (light microscopy) and flow cytometry analysis. Top panel, 20x magnification light microscopy pictographs of a) ER+; b) TNBC and c) Her2+ breast cancer derived CAFs; Lower panel, histograms (dark solid line) depicting CAFs staining for (left to right): EpCAM, FAP, CD45, and CD31; light grey lines depict histogram of CAFs staining with isotype control antibodies.